Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 10:15:4419-4430.
doi: 10.2147/OPTH.S335197. eCollection 2021.

Characterization of Polybacterial versus Monobacterial Conjunctivitis Infections in Pediatric Subjects Across Multiple Studies and Microbiological Outcomes with Besifloxacin Ophthalmic Suspension 0.6

Affiliations

Characterization of Polybacterial versus Monobacterial Conjunctivitis Infections in Pediatric Subjects Across Multiple Studies and Microbiological Outcomes with Besifloxacin Ophthalmic Suspension 0.6

Joseph M Blondeau et al. Clin Ophthalmol. .

Abstract

Introduction: The choice of empiric therapy for bacterial conjunctivitis should be guided by an awareness of typical causative pathogen distributions. Bacterial conjunctivitis can be polybacterial, although pediatric-specific data are lacking.

Methods: This was a post-hoc analysis of data in pediatric subjects (1-17 years) from five bacterial conjunctivitis trials evaluating besifloxacin ophthalmic solution 0.6%.

Results: Of the 730 pediatric subjects with culture-confirmed conjunctivitis, nearly one-fourth (23.6%) had polybacterial infections and three-fourths (76.4%) had monobacterial infections at baseline. In both polybacterial and monobacterial infections, the most prevalent organisms were Haemophilus influenzae, Streptococcus pneumoniae, Staphylococcus aureus, and Streptococcus mitis/S. mitis group. In polybacterial versus monobacterial infections, S. mitis/S. mitis group (8.7% vs 4.3%; P=0.032) and Moraxella catarrhalis (4.7% vs 0.5%; P<0.001) were identified more frequently, whereas S. pneumoniae (14.0% vs 28.1%; P<0.001) was identified less frequently, as the dominant infecting species. MICs for individual species were similar for tested antibiotics regardless of polybacterial or monobacterial infection, except Staphylococcus epidermidis for which fluoroquinolone MICs were ≥3 dilutions higher for isolates of this species sourced from polybacterial compared to monobacterial infections. Treatment with besifloxacin resulted in microbial eradication in 79.1% of polybacterial and 92.3% of monobacterial infections (P≤0.005 vs vehicle).

Discussion: One in four pediatric bacterial conjunctivitis infections is polybacterial, highlighting the need for a broad-spectrum antibiotic when choosing empiric therapy.

Keywords: besifloxacin; conjunctivitis; minimum inhibitory concentration; pediatric; polybacterial.

PubMed Disclaimer

Conflict of interest statement

HH DeCory & CM Sanfilippo are employees of Bausch Health US, LLC. Statistical analysis was conducted by HM Proskin, funded by Bausch Health US, LLC. JM Blondeau has received independent research grants from Bausch Health US, LLC. The authors report no other conflicts of interest in this work.

Figures

Figure 1
Figure 1
Distribution of subjects.
Figure 2
Figure 2
Dominant, secondary, tertiary, and quaternary infecting species at baseline in polybacterial conjunctivitis infections. Dominant bacterial species are shown in the inner ring, whereas secondary, tertiary, and quaternary infecting bacterial species are shown by rank order moving outwards by ring. Only those polybacterial infections in which the same dominant species was identified in more than 10 infections are presented.

Similar articles

References

    1. Hovding G. Acute bacterial conjunctivitis. Acta Ophthalmol. 2008;86:5–17. doi:10.1111/j.1600-0420.2007.01006.x - DOI - PubMed
    1. Block SL, Hedrick J, Tyler R, et al. Increasing bacterial resistance in pediatric acute conjunctivitis (1997–1998). Antimicrob Agents Chemother. 2000;44:1650–1654. doi:10.1128/AAC.44.6.1650-1654.2000 - DOI - PMC - PubMed
    1. Buznach N, Dagan R, Greenberg D. Clinical and bacterial characteristics of acute bacterial conjunctivitis in children in the antibiotic resistance era. Pediatr Infect Dis J. 2005;24:823–828. doi:10.1097/01.inf.0000178066.24569.98 - DOI - PubMed
    1. Weiss A, Brinser JH, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr. 1993;122(1):10–14. doi:10.1016/S0022-3476(05)83479-1 - DOI - PubMed
    1. Azari AA, Barney NP. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA. 2013;310(16):1721–1729. doi:10.1001/jama.2013.280318 - DOI - PMC - PubMed

LinkOut - more resources